HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attenuation of galactose-induced cataract by pyruvate.

Abstract
Data in the present paper demonstrate a significant inhibition in the progress of sugar cataract formation by systemic administration of pyruvate. The formation of the cataract was induced by feeding young rats a diet containing 30% galactose. All animals fed this diet developed nuclear lens opacity by the end of 30 days. This was delayed if the diet and water contained, in addition, 2% sodium pyruvate. The incidence of cataract in the latter group was 0% at day 30 and only 25% at day 55. Physiologically, the inhibition was associated with the prevention of lens membrane damage as reflected by its ability to maintain transport of rubidium ions against a concentration gradient; decreased tissue hydration as indexed by the lens wet weight; inhibition of protein glycation, and higher levels of ATP. Since pyruvate, being a normal tissue metabolite, is likely to be non-toxic, the findings are considered useful for further pharmacological studies with this and other similar metabolites, relevant to protection against various secondary complications of diabetes and galactosemia.
AuthorsS D Varma, P S Devamanoharan, A R Rutzen, A H Ali, M Henein
JournalFree radical research (Free Radic Res) Vol. 30 Issue 4 Pg. 253-63 (Apr 1999) ISSN: 1071-5762 [Print] England
PMID10230804 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Glycoproteins
  • Rubidium Radioisotopes
  • Pyruvic Acid
  • Adenosine Triphosphate
  • Galactose
Topics
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Aqueous Humor (metabolism)
  • Cataract (chemically induced, prevention & control)
  • Diet
  • Galactose (administration & dosage)
  • Galactosemias (complications)
  • Glycoproteins (metabolism)
  • Glycosylation
  • Lens, Crystalline (anatomy & histology, metabolism)
  • Male
  • Pyruvic Acid (administration & dosage, pharmacokinetics, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Rubidium Radioisotopes (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: